# Amoxicillin-induced linear IgA bullous dermatosis mimicking erythema multiforme: a case report

**Authors:** Marion Silagy, Priscille Carvalho, Billal Tedbirt, Clémence Tamarit, Marion Carrette, Florence Tétart, Alexis Lefebvre

PMC · DOI: 10.1093/skinhd/vzae024 · Skin Health and Disease · 2025-02-25

## TL;DR

A 77-year-old man developed a skin condition resembling erythema multiforme after taking amoxicillin, diagnosed as linear IgA bullous dermatosis.

## Contribution

This case highlights amoxicillin as a potential trigger for linear IgA bullous dermatosis, mimicking erythema multiforme.

## Key findings

- The patient's skin lesions showed linear IgA deposition at the dermal–epidermal junction.
- Discontinuation of amoxicillin led to complete remission within 7 days with no relapse after 4 months.
- Herpes simplex virus and other infections were ruled out as causes.

## Abstract

A 77-year-old man presented with a cutaneous rash of 3 days’ duration. Seven days before onset, the patient reported a bronchopulmonary infection treated with amoxicillin. Physical examination revealed multiforme cutaneous lesions, involving the armpits, pubis, genitals and lower back. In the lower back area, lesions were erythematous, purplish targetoid-like with multiple concentric circles. In places, bullae and postblistering erosions could be seen. In places, a ‘string of pearls’ pattern could be observed. Nikolsky sign was negative. Herpes simplex virus polymerase chain reaction (PCR) on mucosal erosions was negative. Multiplex nasopharyngeal PCR was negative for influenza virus, COVID-19 and Mycoplasma pneumoniae. Histopathological examination revealed spontaneous subepithelial cleavage with neutrophilic ­microabscesses. Direct immunofluorescence showed linear IgA deposition at the dermal–epidermal junction, confirming the diagnosis of linear IgA bullous dermatosis. Skin lesions were treated with topical clobetasol propionate cream and oral mucosa with corticosteroid mouth rinses. The disease course was marked by complete remission 7 days after amoxicillin discontinuation. There was no relapse after 4 months of follow-up.

## Linked entities

- **Chemicals:** amoxicillin (PubChem CID 33613), clobetasol propionate (PubChem CID 32798)
- **Diseases:** erythema multiforme (MONDO:0006545)

## Full-text entities

- **Genes:** CD79A (CD79a molecule) [NCBI Gene 973] {aka IGA, IGAlpha, MB-1, MB1}
- **Diseases:** cutaneous rash (MESH:D005076), IgA bullous dermatosis (MESH:D062027), COVID-19 (MESH:D000086382), Skin lesions (MESH:D012871), erosions (MESH:D014077), erythema multiforme (MESH:D004892), bronchopulmonary infection (MESH:D001997), cutaneous lesions (MESH:D009059)
- **Chemicals:** Amoxicillin (MESH:D000658), clobetasol propionate (MESH:D002990)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mycoplasmoides pneumoniae (Filterable agent of primary atypical pneumonia, species) [taxon 2104]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11924383/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11924383/full.md

## References

9 references — full list in the complete paper: https://tomesphere.com/paper/PMC11924383/full.md

---
Source: https://tomesphere.com/paper/PMC11924383